Blog

Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations – News-Medical.net


News-Medical.net

Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations
News-Medical.net
Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic
Editorial: Tampa Bay's leadership on immunotherapyTampabay.com


Some Cancer Cells Hide Mutations to Impair Immune Recognition, Study FindsImmuno-Oncology News
Nanoparticles awaken immune cells to fight cancer | Science | AAASScience Magazine
The Kiplinger Washington Editors, Inc. (subscription)
all 11 news articles »

2017-01-06 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.